SFas and FasL in etiopathogenesis of autoimmune diseases of the thyroid gland and nodular forms of goiter

M. I. Sheremet, V. O. Shidlovskyy, Y. V. Girla, N. P. Tkachuk, A. G. Tibirna, V. P. Dorosh


Sheremet М. І., Shidlovskyy V. О., Girla Y. V., Tkachuk N. P., Tibirna A. G., Dorosh V. P. SFas and FasL in etiopathogenesis of autoimmune diseases of the thyroid gland and nodular forms of goiter. Journal of Education, Health and Sport. 2015;5(12):41-49. ISSN 2391-8306. DOIhttp://dx.doi.org/10.5281/zenodo.34845



Formerly Journal of Health Sciences. ISSN 1429-9623 / 2300-665X. Archives 2011–2014http://journal.rsw.edu.pl/index.php/JHS/issue/archive



Specyfika i zawartość merytoryczna czasopisma nie ulega zmianie.

Zgodnie z informacją MNiSW z dnia 2 czerwca 2014 r., że w roku 2014 nie będzie przeprowadzana ocena czasopism naukowych; czasopismo o zmienionym tytule otrzymuje tyle samo punktów co na wykazie czasopism naukowych z dnia 31 grudnia 2014 r.

The journal has had 5 points in Ministry of Science and Higher Education of Poland parametric evaluation. Part B item 1089. (31.12.2014).

© The Author (s) 2015;

This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland and Radom University in Radom, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,

provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License

(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial

use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

Received: 25.09.2015. Revised 25.10.2015. Accepted: 30.11.2015.




М. І. Sheremet, V. О. Shidlovskyy*, Y. V. Girla, N. P. Tkachuk,

A. G. Tibirna*, V. P. Dorosh


Bukovinyan State Medical University, Chernivtsy, Ukraine

*I.Y. Horbachevsky State Medical University, Ternopol, Ukraine

*PhD, assistant professor, USMF ,,Nicolae TestemiţanuChisinau, Moldova


AbstractThe objective of this research was to check whether the apoptotic inhibitor sFas (soluble fibroblaste-assosiated cell surface) and the apoptotic inducer FasL (fibroblaste-assosiated cell surface ligand) are differentially present in two opposite phenotypes of autoimmune thyroid disorders (AITD) and nodular goiter (NG). However, in contrast to GD (Graves’ disease), decreased sFas in HT (Hashimoto’s thyroiditis) increased FasL, indicate destruction of thyrocytes. In cases of thyroid NG, sFas may provide a key protective signal that helps the cells to avoid ap­optosis in a hostile environment.

Keywords: Autoimmune thyroid disease, Fas ligand, soluble Fas, Graves’ disease, Hashimoto’s thyroiditis, nodular goiter.


autoimmune thyroid disease, Fas ligand, soluble Fas, Graves’ disease, Hashimoto’s thyroiditis, nodular goiter.

Full Text:



Чекаліна Н. І. Сучасні уявлення про автоімунний тиреоїдит: етіологія та патогенез / Н. І. Чекаліна, Ю.М. Казаков, Є. Є. Петров // Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії: Науково-практичний ж-л. – 2012. – Т. 12(4). – С. 229–232.

Andrikoula, M., Kolaitis, N., Vartholomatos, G., et al.: Serum levels of soluble Fas in patients with multinodular goiter. Immunol. Investig., 38(5): 398-407, 2009.

Ashkenazi, A. and Dixit, V.M.: Death receptors: signaling and modulation. Science, 281: 1305-1308, 1998.

Basolo, F., Fiore, L., Baldanzi, A., et al.: Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma. Lab. Invest., 80: 1413-9, 2000.

Bellgrau, D., Gold, D., Selawry, H., et al.: A role for CD95 ligand in preventing graft rejection. Nature, 377: 630-632, 1995.

Bretz, J.D., Patricia, L., Arscott, Myc A., et al.: Inflammatory cytokine regulation of Fas mediated apoptosis in thyroid follicular cells. J. Biological Chem., 274 (36): 25433-38, 1999.

Brunner, T., Mogil, R. J., LaFace, D., et al.: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature, 373: 441-444, 1995.

Cheng, J., Zhou, T., Liu, C., et al.: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 263: 1759-62, 1994.

Chistiakov, DA. Immunogenetics of Hashimoto’s thyroiditis. J. Autoimmun. Dis. 2005; 2: 1-21.

Fountoulakis, S., Kolaitis, N., Philippou, G., et al.: Differential regulation of soluble Fas in patients with autoimmune thyroid disease. Endocrine Abstracts, 11: 842, 2006.

Fugazzola, L, Cirello, V, Beck-Peccoz, P. Microchimerism and endocrine disorders. J. Clin Endocrinol. Metab. 2012; 97:1452.

Giordano, C., Stassi, G., De Maria, R., et al.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science, 275: 960-963, 1997.

Glick, AB, Wodzinski, A, Fu, P, et al. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013; 23:871.

Griffith, T.S., Brunner, T., Fletcher, S.M., et al.: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270: 1189-1119, 1995.

Hiromatsu, Y., Bednarczuk, T., Soyejima, E., et al.: Increased serum soluble Fas in Patients with Graves’ disease. Thyroid, 9: 341-345, 1999.

Hiromatsu, Y., Kakau, H., Mukai, T., et al.: Immunohistochemical analysis of Bcl-2, Bax and Bak expression in thyroid glands from patients with Graves’ disease. J. Endocrinol., 51: 399-405, 2004.

Kotani, T., Aratake, Y., Hirai, K., et al.: Apoptosis in thyroid tissue from patients with Hashimoto’s thyroiditis. Autoimmunity, 20: 231-236, 1995.

McLachlan, SM, Nagayama, Y, Pichurin, PN, et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology 2007; 148:5724.

Mountz, J.D., Zhang, H.G., Hsu, H.C., et al.: Apoptosis and cell death in the endocrine system. Recent Progress Horm. Res., 54: 235-269, 1999.

Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., et al.: FLICE, a novel FADD-homologous ICE/CED- 3-like protease, is recruited to the CD95 (Fas/APO- 1) death-inducing signaling complex. Cell, 85(6): 817-27, 1996.

Nagata, S.: Fas and Fas ligand: a death factor and its receptor. Adv. Immunol., 57: 129-144, 1994.

Owen-Schaub, L. B., Yonehara, S., Crump, W. L. D., et al.: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol., 140(1): 197-205, 1992.

Stassi, G., Todaro, M., Bucchieri, F. et al. Fas/Fas Ligand-Driven T Cell Apoptosis as a Consequence of Ineffective Thyroid Immunoprivilege in Hashimoto’s Thyroiditis. J. Immunol., 1999; 162:263-267.

Steller, H.: Mechanisms and genes of cellular suicide. Science, 267: 1445-1449, 1995.

Strand, S., Hofmann, W.J., Hug, H., et al.: Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion? Nat. Med., 2: 1361-1370, 1996.

Suda, T., Takahashi, T., Golstein, P., et al.: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell., 75: 1169-1178, 1993.

Tamura, M., Kimura, H., Koji, T., et al.: Role of apoptosis of thyrocytes in a rat model of goiter: A possible involvement of Fas system. Endocrinology, 139: 3646-3653, 1998.

Tanimoto, C., Hirakawa, S., Kawasaki, H., et al.: Apoptosis in thyroid diseases: a histochemical study. Endocr. J, 42: 193-201, 1995.

Vlaeminck-Guillem V., d’Herbomez-Boidein, M., Decoulx, M., et al.: Apoptosis and the thyroid: the Fas pathway. Presse Med., 20-30(2): 74-80, 2001.

White, E.: Life, death, and the pursuit of apoptosis. Genes Dev., 10(1): 1-15, 1997.


  • There are currently no refbacks.

Copyright (c) 2015 Journal of Education, Health and Sport formerly Journal of Health Sciences

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014


POL-index 2011 - 2014


BASE 2011 - 2014




Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI


Find a library that holds this journal: http://worldcat.org/issn/23918306

Journal Language(s): English 

PBN Poland






Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2  www.ukw.edu.pl Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy http://ojs.ukw.edu.pl/index.php/johs  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.


ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase Index.com.

Website: www.infobaseindex.com

Universal Impact Factor 1.78 for year 2012. (http://www.uifactor.org/AppliedJournals.aspx)

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski